Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-05

Clinical Trial Update: Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 randomized controlled trial evaluating different gabapentin dosing regimens for treating erythema and flushing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic) | Phase 1 | Status: COMPLETED